Clinical Experience with the PillCam Patency Capsule prior to Video Capsule Endoscopy: A Real-World Experience
Table 1
Demographic and clinical characteristics of the study population: the main indications for the planned VCE were suspected Crohn’s disease of the small intestine or gastrointestinal bleeding. All 38 included patients had at least one risk factor for a capsule retention.
Parameter
Age [years]
61,5 14–88
Sex [male/female]
17/21
Indication for VCE
Suspected CD of the small bowel
10 (26%)
Anemia/gastrointestinal bleeding
26 (68%)
Suspected tumor
2 (5%)
Documented risk factor for capsule retention
One documented risk factor for capsule retention
8 (21%)
More than one documented risk factor for capsule retention
30 (79%)
Suspected or known Crohn’s disease
11 (29%)
Previous abdominal surgery
21 (55%)
Multiple previous abdominal surgeries
11 (29%)
Previous subileus or ileus
2 (5%)
Suspected tumor in imaging
4 (11%)
High dose and/or longtime NSAID use
8 (21%)
VCE: video capsule endoscopy, CD: Crohn’s disease, and NSAID: nonsteroidal anti-inflammatory drug.